Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2020-03-20
2020-12-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Kidney Injury in Critical COVID-19: Outcomes and Risks
NCT07089693
Acute Kidney Injury Risk in COVID-19
NCT04874779
Acute Kidney Injury and Acute Kidney Disease in COVID-19
NCT04353583
COVID-19 RELATED KIDNEY DAMAGE
NCT04706325
The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease
NCT04874753
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
COVID-19 patients with acute kidney injury
COVID-19 patients with acute kidney injury
duration of hospitalization, mortality rate
duration of hospitalization, mortality rates of patients hospitalised for COVID-19 evaluated and compared in patients with and without acute kidney injury.
COVID-19 patients without acute kidney injury
COVID-19 patients without acute kidney injury
duration of hospitalization, mortality rate
duration of hospitalization, mortality rates of patients hospitalised for COVID-19 evaluated and compared in patients with and without acute kidney injury.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
duration of hospitalization, mortality rate
duration of hospitalization, mortality rates of patients hospitalised for COVID-19 evaluated and compared in patients with and without acute kidney injury.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients hospitalised with COVID-19 with Acute Kidney Injury
Exclusion Criteria
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uşak University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zelal Adibelli
Asistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zelal Adibelli
Role: PRINCIPAL_INVESTIGATOR
Uşak University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Usak University
Uşak, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UsakU3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.